Janice Gabrilove is an Oncology physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 246 publications with 17,385 citations (h-index 49). By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1190 5th Avenue Guggenheim Pavill
Mount Sinai Hospital-Ruttenberg Treatment Center
New York, NY 10029
Telephone
212-241-6756Registry record last updated 8 Jul 2007.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BeiGene USA, Inc.Program year20221 payment
- Amgen Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
11 NIH research awards on record, funded 1985–2026 per NIH RePORTER. The latest:
- The Tisch Cancer Institute (TCI) Paul Calabresi K12 Career Development Award for Clinical Oncology
Icahn School of Medicine at Mount Sinai
FY2026$474,414K12CA270375 - Cancer Research Training and Education Coordination
Icahn School of Medicine at Mount Sinai
FY2026$91,800P30CA196521
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- What is well-being? A scoping review of the conceptual and operational definitions of occupational well-being
Journal of Clinical and Translational Science
2023 - Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis
Evidence-Based Medicine
2020 - Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID‐19
British Journal of Haematology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Gregg Stone, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Donna Mancini, MD
Icahn School of Medicine at Mount Sinai
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”